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Introduction
Acute pancreatitis (AP) is a leading cause of hospital-
ization for gastrointestinal disorders [1]. Because of a
substantially high mortality of up to 20–30 % in severe
cases, early identification of patients who might require
transfer to an intensive care unit (ICU) is essential [2].
What is new in the assessment of severity?
The original Ranson criteria from 1974, last modified in
2012, have been followed by several new and in part
much more complex scoring systems; however, these
have only increased diagnostic performance modestly
(AUC from 0.57 to 0.74) [3]. Recent findings suggest that
the presence of under- or overweight, development or
persistence of organ failure, and assessment of biomark-
ers, such as cytokine levels might help to further improve
identification of high-risk patients [4, 5] (Fig. 1).
What is new in therapy?
Several interventions have been identified as critical
within 48 h, here in particular fluid resuscitation, anal-
gesia and nutritional support.
Fluid therapy
Sustainable scientific and in particular clinical data on
how to guide fluid therapy in this disease are still scarce.
A recent review underlined the concept of early aggres-
sive resuscitation, guided by the clinical estimation, and
the assessment of BUN and haematocrit levels [6]. Recent
results from a small retrospective single-centre cohort
study seem to support such an aggressive approach in
severe AP, whereas data from another, but prospective
study reported that excessive hydration (10–15 ml/kg/h),
where the goal was set to obtain a haematocrit of 35 %,
resulted in increased organ failure, respiratory insuffi-
ciency and mortality [7, 8]. Whether guiding fluid therapy
by cardiac output measurements and/or assessment of
fluid responsiveness will lead to improvements in the
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management of this important therapeutic action with
positive effects of outcome, as shown in recent experi-
mental studies, needs to be confirmed in clinical settings
[9].
Analgesia
Because of the severity of pain in severe AP, opioids are
widely used. However, there is still uncertainty whether
their side effect of inducing spasms of the smooth muscles
may hide the resolution of the disease or even induce
additional pain. Data of a recent Cochrane analysis do not
support those concerns, but, as stated by the authors, this
analysis is founded only on a very limited number of
heterogeneous trials (Cochrane Database Syst Rev Jul
26;7:CD009179).
Epidural anaesthesia, which by far would be most
effective in pain control, seems to beneficially influence
the course of disease by improving pancreatic microcir-
culation and tissue oxygenation [10]. However, concerns
with regard to concomitant derangements of coagulation
and systemic inflammation so far have prevented its
broader clinical use.
Nutritional support
Because enteral nutrition can stimulate pancreatic and
intestinal secretions, the pancreatic rest concept has been
a dogma in managing severe AP. However, bowel rest is
associated with intestinal atrophy, bacterial overgrowth,
and is responsible for elevated endotoxin and cytokines
levels, bacterial translocation and SIRS induction. This is
associated with a higher risk of infected pancreatic
necrosis. So, because of its beneficial effects on tissue of
the intestinal mucosa and the splanchnic blood flow, the
concept that enteral nutrition ‘worsens’ pancreatitis has
diminished greatly over recent years. In a recent meta-
analysis including eight randomized controlled studies
and 381 patients, enteral nutrition compared with par-
enteral nutrition decreased infectious complications and
mortality [11]. The use of early enteral nutrition (within
48 h of admission) has proven to be beneficial in patients
with AP as it improves clinical outcomes by reducing the
number of infections, particularly pancreatic infections
(OR 0.49; 95 % CI 0.31–0.78) [12]. Recently, in less
severe illness (APACHE II score 11; 6 % of the patients
with multiple organ failure), a trial did not show the
superiority of enteral nutrition within 24 h compared with
oral diet after 72 h, in reducing the rate of infection or
death [13]. On the basis of the assumption that gastric
food administration increases the risk of abdominal pain
exacerbation, nasojejunal feeding has long been favoured.
However, exclusive gastric feeding succeeds with the
delivery of nutritional targets in 90 % of patients [14].
The type of dietary mixture used did not appear decisive,
and the effect of immunonutrition, glutamine supple-
mentation and probiotics has not been demonstrated
(Cochrane Database Syst Rev Mar 23;3:CD010605).
How is infected necrosis managed?
Infected necrosis occurs in 40–70 % of patients in the
second or third week of the illness and is the leading
cause of late mortality. The onset or worsening of organ
failure in a septic context must raise suspicion of infected
necrosis, and fine needle CT-guided aspiration should be
considered. Antibiotics should be administered as soon as
the results of the Gram stain are available. More conser-
vative intervention than surgical necrosectomy now
predominates. A step-up approach of percutaneous drai-
nage followed, if necessary, by a minimally invasive
surgical necrosectomy significantly reduces the rate of
major complications and mortality by 29 % compared
with open surgery [15]. Mouli et al. recently reported that
a conservative initial approach with antimicrobial therapy
with or without PCD was a successful approach for 64 %
of patients with infected necrosis [16]. Moreover, post-
ponement of a surgical necrosectomy provides an
opportunity for acute collections to become walled-off
and liquefied. A randomized study with a very small
number of patients requiring secondary pancreatic
debridement found endoscopic transgastric necrosectomy
to be superior to surgical necrosectomy with respect to the
overall rate of major complications or mortality (20 vs.
80 %) [17].
What do we do for biliary pancreatitis?
Gallstone disease is ranked first among the causes of
pancreatitis in all the series (40–70 %) and can progress
rapidly to severe AP. Although transabdominal ultra-
sonography (US) exhibits low sensitivity (ranging from
20 to 50 %) for detecting choledocholithiasis, repeated
examinations indicate an accuracy rate as high as 83 %
[18]. However, endoscopic ultrasound is clearly superior,
with a sensitivity and specificity greater than 90 % in the
detection of bile duct stones. A recent Cochrane Database
search found no benefit from early ERCP with respect to
mortality and local complications, claiming that ERCP is
not needed in patients without evidence of biliary
obstruction (Cochrane Database Syst Rev May
16;5:CD009779). In contrast, urgent ERCP within the
first 24 h is indicated in severe AP with co-existing
cholangitis or biliary obstruction [19] (Fig. 1).
What about intra-abdominal hypertension
and abdominal compartment syndrome?
The overall incidence of intra-abdominal hypertension
(IAH) and abdominal compartment syndrome (ACS) in
patients with severe AP is around 50–75 and 10–25 %,
respectively [20]. The development of IAH and ACS in
these patients has a major impact on morbidity and mortality
and results from a combined effect of the inflammatory
process itself and the iatrogenic aggressive fluid resuscita-
tion. Raised intra-abdominal pressure causes upward shift
of both hemidiaphragms and leads to compression atelec-
tasis and hypercapnia. This, in combination with bilateral
pleural effusions, may result in severe hypoxia.
When all non-operative measures fail to decrease
intra-abdominal pressure and especially in the setting of
primary ACS, one should consider immediate midline
decompressive laparotomy since this can be life-saving.
Newer and less-invasive methods have been recently
suggested. A subcutaneous linea alba fasciotomy (SLAF)
can be performed by utilizing three short horizontal skin
incisions with the peritoneum closed avoiding a true open
abdomen. SLAF needs further clinical evaluation and
does result in a giant midline hernia with associated need
for surgery at a later stage.
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Fig. 1 Management of severe
pancreatitis. BMI body mass
index, ATB antibiotics, ERCP
endoscopic retrograde
cholangiopancreatography, ACS
abdominal compartment
syndrome, PCD percutaneous
(or endoscopic) drainage
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